Effect of an enhanced nose-to-brain delivery of insulin on mild and progressive memory loss in the senescence-accelerated mouse
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-092-Tuesday
- By: KAMEI, Noriyasu (Kobe Gakuin University, Faculty of Pharmaceutical Sciences, Kobe, Japan)
- Co-author(s): Noriyasu Kamei: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan
Misa Tanaka: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan
Hayoung Choi: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan
Nobuyuki Okada: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan
Takamasa Ikeda: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan
Mariko Takeda-Morishita: Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan - Abstract:
Backgrounds
Insulin is now considered to be a new drug candidate for treating dementias, such as Alzheimer’s disease, whose pathologies are linked to insulin resistance in the brain. Our recent work has clarified that a noncovalent strategy involving cell-penetrating peptides (CPPs) can increase the direct transport of insulin from the nasal.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023